Montelukast Sodium Tablet, Chewable
Product Images NDC 65162-771

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 65162-771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6faadd90-figure-01 (Montelukast Sodium Chewable Tablets 1)

6faadd90-figure-01 (Montelukast Sodium Chewable Tablets 1)
A line graph showing change in height (cm) over weeks on treatment, comparing Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo groups. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm. Data points are plotted with different markers for each treatment group.*
FDA Label Image

6faadd90-figure-02 (Montelukast Sodium Chewable Tablets 2)

6faadd90-figure-02 (Montelukast Sodium Chewable Tablets 2)
Chemical structure of Montelukast, the active ingredient in Montelukast Sodium tablets, showing its molecular arrangement including aromatic rings, sulfate group, and sodium carboxylate moiety.*
FDA Label Image

6faadd90-figure-03 (Montelukast Sodium Chewable Tablets 3)

6faadd90-figure-03 (Montelukast Sodium Chewable Tablets 3)
A line graph depicting mean percent change from baseline over weeks in treatment for Montelukast Sodium chewable tablets compared to placebo. The x-axis represents treatment weeks including a washout period, while the y-axis shows percent change from baseline. Montelukast Sodium shows a higher percent increase over time compared to placebo.*
FDA Label Image

4 mg 30 Ct Label (Montelukast Sodium Chewable Tablets 4)

4 mg 30 Ct Label (Montelukast Sodium Chewable Tablets 4)
Label for Montelukast Sodium Chewable Tablets, USP 4 mg, for pediatric patients aged 2 to 5 years. The label includes an image of a single pink oval tablet imprinted with 'A71.' It indicates the package contains 30 tablets with the designation Rx only and mentions Amneal Pharmaceuticals LLC as the distributor. Storage instructions specify controlled room temperature and protection from moisture and light.*
FDA Label Image

5 mg 30 Ct Label (Montelukast Sodium Chewable Tablets 5)

5 mg 30 Ct Label (Montelukast Sodium Chewable Tablets 5)
Label for Montelukast Sodium Chewable Tablets, USP 5 mg designed for pediatric patients 6 to 14 years old. The label states the drug is prescription-only and contains 30 tablets. It includes storage instructions, distributor information (Amneal Pharmaceuticals LLC), and a barcode. The label also shows a pink round tablet image marked with 'A72.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.